Stoke Therapeutics (STOK) Total Liabilities (2022 - 2025)
Historic Total Liabilities for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to $52.2 million.
- Stoke Therapeutics' Total Liabilities fell 1478.12% to $52.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.2 million, marking a year-over-year decrease of 1478.12%. This contributed to the annual value of $42.5 million for FY2024, which is 3815.67% down from last year.
- According to the latest figures from Q3 2025, Stoke Therapeutics' Total Liabilities is $52.2 million, which was down 1478.12% from $49.6 million recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Total Liabilities ranged from a high of $77.1 million in Q2 2022 and a low of $42.5 million during Q4 2024
- Moreover, its 4-year median value for Total Liabilities was $66.7 million (2023), whereas its average is $64.0 million.
- Examining YoY changes over the last 5 years, Stoke Therapeutics' Total Liabilities showed a top increase of 251.18% in 2024 and a maximum decrease of 3815.67% in 2024.
- Stoke Therapeutics' Total Liabilities (Quarter) stood at $71.2 million in 2022, then dropped by 3.43% to $68.8 million in 2023, then plummeted by 38.16% to $42.5 million in 2024, then increased by 22.63% to $52.2 million in 2025.
- Its last three reported values are $52.2 million in Q3 2025, $49.6 million for Q2 2025, and $56.8 million during Q1 2025.